Thursday, June 25

Probe Intensifies as Rajasthan Health Authorities Halt Use of Medicines and IV Fluids Linked to Post-Delivery Complications

A major health scare has emerged at Paota District Hospital in Jodhpur, Rajasthan, after eight women developed serious medical complications following Caesarean section deliveries. In response, health authorities have suspended the use of 25 medicines and injections, including intravenous (IV) fluids administered during the procedures, pending a detailed investigation.

According to officials, samples of all medicines, injections, consumables, and IV fluids used in the affected cases have been collected and sent for laboratory testing. The Medical Department has directed hospitals not to use these products until test reports are received.

Sodium Lactate IV Fluid Under Scanner

Preliminary findings suggest that the women were administered Sodium Lactate IV injections during treatment. Hospital authorities revealed that the batch under suspicion had arrived at the facility approximately a week before the incident and was reportedly being used for the first time.

As a precautionary measure, authorities have suspended the use of the entire batch while investigations continue. An inquiry has been initiated at the medical college level, while a team from AIIMS has been tasked with conducting an independent probe into the matter.

Women Developed Complications After Caesarean Deliveries

The incident occurred on June 20 at Paota District Hospital, where several women reportedly experienced severe health complications shortly after undergoing C-section deliveries. The situation prompted an emergency medical response and triggered concerns regarding the safety of medicines and consumables used during treatment.

District Collector Alok Ranjan visited the hospital’s medicine store and chaired a review meeting with senior health officials, including Dr B.S. Jodha, Principal of Dr SN Medical College; Dr Kulbir Chopra, PMO of Paota District Hospital; Dr Vikas Rajpurohit, Superintendent of MDM Hospital; and CMHO Dr S.S. Shekhawat.

Two Patients Referred to AIIMS After Kidney Complications

Dr Kulbir Chopra stated that Sodium Lactate IV fluid is routinely administered before and after Caesarean deliveries and is commonly used during various surgical procedures. He emphasized that all other medicines and treatment protocols remained standard and unchanged.

Hospital officials said that six of the affected women are currently stable and recovering. However, two patients, identified as Lalita and Sonal, developed severe complications, including kidney impairment, requiring dialysis treatment. Both patients have been referred to AIIMS for specialised medical care.

Families Demand Thorough Investigation

Family members of the affected women have demanded a comprehensive inquiry into the incident. They alleged that the patients suffered excessive bleeding, reduced urine output, and other serious complications shortly after childbirth.

Meanwhile, hospital authorities have suspended surgical procedures at Paota District Hospital until reports related to medicines, consumables, and the operation theatre environment are received. Patients requiring surgeries are currently being referred to Mathuradas Mathur Hospital.

Cause Yet to Be Determined

Health officials have stated that the exact cause behind the complications remains unknown and will be determined only after laboratory reports and investigation findings are available. The outcome of the probe is expected to clarify whether the complications were linked to the IV fluid batch, medicines, consumables, or any other clinical factor.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version